Venturi Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Venturi Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$609K	Buy	17,984 +4,063	+29%	+$135K	0.02%	335
2026 Q1	$419K	Buy	+13,921	New	+$448K	0.02%	388
2025 Q1	–	Sell	-893	Closed	-$19.7K	–	1696
2024 Q4	$19.7K	Sell	893 -2,409	-73%	-$43.8K	﹤0.01%	1266
2024 Q3	$59.5K	Buy	+3,302	New	+$57.8K	﹤0.01%	710
2016 Q3	–	Sell	-4,111	Closed	-$206K	–	145
2016 Q2	$206K	Sell	4,111 -255	-6%	-$13.6K	0.07%	136
2016 Q1	$234K	Buy	+4,366	New	+$256K	0.09%	123

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Venturi Wealth Management's TEVA Position: Q2 2026 in Review

Venturi Wealth Management increased its Teva Pharmaceuticals (TEVA) stake by 29% in Q2 2026, buying an estimated $135K and bringing the position to 17,984 shares worth $609K. The position accounts for 0.02% of the portfolio, ranked #335.

Venturi Wealth Management first reported a position in TEVA in Q1 2016 and has held it in 6 quarters since. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Venturi Wealth Management held 17,984 shares of Teva Pharmaceuticals worth $609K as of Q2 2026.
Venturi Wealth Management bought 4,063 Teva Pharmaceuticals shares in Q2 2026, an estimated $135K.
Teva Pharmaceuticals made up 0.02% of Venturi Wealth Management's portfolio in Q2 2026, its #335 holding.
Venturi Wealth Management first reported a position in Teva Pharmaceuticals in Q1 2016 and has held it in 6 quarters since.
675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.